Skip to main content

Advertisement

Log in

Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature

  • Case Report
  • Published:
Child's Nervous System Aims and scope Submit manuscript

Abstract

Hemangioblastomas are benign vascular tumors that can occur throughout the central nervous system (CNS) sporadically or in association with von Hippel-Lindau (VHL) disease. We present a case of an 11-year-old girl with a hemangioblastoma that tested negative for germline mutation of VHL disease at the time of diagnosis. Our patient went on to have multiple recurrences and further areas of concern for disease within the CNS. Repeat VHL testing was pursued many years later and remained negative for germline mutations. However, next-generation sequencing (NGS) testing on prior tumor tissue returned positive for VHL somatic mutations. The diagnosis of VHL mosaicism has important implications on management and risk of recurrence of hemangioblastoma, along with the need for close follow-up with surveillance imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Woodward ER, Wall K, Forsyth J, Macdonald F, Maher ER (2007) VHL mutation analysis in patients with isolated central nervous system haemangioblastoma. Brain 130:836–842

    Article  PubMed  Google Scholar 

  2. Oldfield LE, Grzybowski J, Grenier S et al (2022) VHL mosaicism: the added value of multi-tissue analysis. NPJ Genom Med 7:21

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Coppin L, Grutzmacher C, Crepin M et al (2014) VHL mosaicism can be detected by clinical next-generation sequencing and is not restricted to patients with a mild phenotype. Eur J Hum Genet 22:1149–1152

    Article  PubMed  Google Scholar 

  4. Santarpia L, Sarlis NJ, Santarpia M, Sherman SI, Trimarchi F, Benvenga S (2007) Mosaicism in von Hippel-Lindau disease: an event important to recognize. J Cell Mol Med 11:1408–1415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Murgia A, Martella M, Vinanzi C, Polli R, Perilongo G, Opocher G (2000) Somatic mosaicism in von Hippel-Lindau disease. Hum Mutat 15:114

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed equally to the writing of the manuscript.

Corresponding author

Correspondence to Sudarshawn Damodharan.

Ethics declarations

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Informed consent was obtained for publication.

Conflict of interest

None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Whitman, A., Damodharan, S., Bhatia, A. et al. Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature. Childs Nerv Syst 39, 1361–1363 (2023). https://doi.org/10.1007/s00381-023-05859-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00381-023-05859-7

Keywords

Navigation